AusPAR: Hydrochlorothiazide / Valsartan / Amlodipine (as besylate)
Related information
- Australian Public Assessment Reports for prescription medicines (AusPARs)
- Browse AusPARs by active ingredient
- Browse AusPARs by product name
- Browse AusPARs by sponsor
*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
Australian Public Assessment Report
28 September 2010
| AusPAR | |
|---|---|
| Active Ingredient | Hydrochlorothiazide / Valsartan / Amlodipine (as besylate)
|
| Product Name | Exforge HCT / Ejocia HCT
|
| Sponsor | Novartis Pharmaceuticals Australia Pty Limited
|
| Submission Number | PM-2008-03499-3-3
|
| Submission Type | New fixed combination
|
| AusPAR Date | 26 August 2010
|
| Publication Date | 28 September 2010 |